Research Topic: Candida albicans

The ATO gene family governs Candida albicans colonization in the dysbiotic gastrointestinal tract

This study shows that the fungus Candida albicans uses a family of protein transporters called ATO to absorb acetate, a fatty acid produced by gut bacteria. When mice were treated with antibiotics that killed their beneficial bacteria, C. albicans could colonize their guts better if it had working ATO transporters. The research reveals that fungi have evolved special systems to take advantage of nutrients left behind when the normal gut bacteria are disrupted, which helps explain why fungal infections are more common after antibiotic use.

Read More »

Hyphal swelling induced in the phagosome of macrophages

When Candida albicans yeast cells are engulfed by immune cells called macrophages, they transform into thread-like hyphae. Researchers discovered that these hyphae sometimes develop swollen, bulbous compartments rather than maintaining their normal shape. Surprisingly, these swollen fungal cells survive much better inside the hostile macrophage environment than normal-shaped hyphae. This swelling appears to be a clever survival strategy that helps the fungus resist being killed by the immune system.

Read More »

Multilocus sequence typing of Candida albicans isolates from wild and farm animals from southern Italy

Researchers studied a fungal pathogen called Candida albicans found in farm and wild animals in Italy to understand how it spreads between animals and humans. They used genetic analysis to compare isolates from laying hens, wild boars, and lizards with samples from infected humans around the world. The results showed that animal isolates were genetically similar to human clinical samples, suggesting animals could serve as reservoirs for this infection. This research highlights the importance of monitoring fungal diseases in animal populations as part of understanding disease transmission between animals and people.

Read More »

The efficacy of luliconazole and caspofungin on planktonic and biofilm of Candida albicans from different sources

Candida albicans, a common yeast infection organism, can form tough protective structures called biofilms that resist antifungal medications. This study tested two antifungal drugs (luliconazole and caspofungin) against Candida in both regular form and biofilm form. The results showed that while these drugs work well against regular Candida cells, they are much less effective against biofilms, which require 15-171 times higher doses to be inhibited. The strongest biofilms came from vaginal infections, suggesting that different infection types may require different treatment approaches.

Read More »

Evaluation of Antifungal Activity Against Candida albicans Isolates From HIV-Positive Patients with Oral Candidiasis in a Major Referral Hospital, West Java, Indonesia

Researchers in West Java, Indonesia studied fungal infections in the mouths of HIV-positive patients to understand which antifungals work best. They found that a common fungal species called Candida albicans was present in all patients tested, though some resistant strains were discovered. The study showed that certain antifungal medications like voriconazole worked better than others, highlighting the importance of testing which specific medications will be effective for each patient rather than guessing.

Read More »

Overexpression of efflux pump and biofilm associated genes in itraconazole resistant Candida albicans isolates causing onychomycosis

This study examined why some fungal nail infections caused by Candida albicans don’t respond to itraconazole treatment. Researchers found that resistant fungi have higher levels of genes that pump the antifungal drug out of their cells and genes that help them form protective biofilm layers. These findings suggest that combining itraconazole with drugs that block these pumps or disrupt biofilms could be more effective for treating stubborn fungal nail infections.

Read More »
Scroll to Top